Analyses of dose-response in radiotherapy for patients with mature T/NK-cell lymphomas according to the WHO classification

Radiotherapy and Oncology

Volumn 79, Issue 2, 2006, Pages 179-184

  Sakata, Koh ichi ^a   Fuwa, Nobukazu ^b   Kodaira, Takeshi ^b   Aratani, Kazunori ^c   Ikeda, Hikaru ^c   Takagi, Masaru ^d   Nishio, Masamichi ^d   Satoh, Masaaki ^a   Nakamura, Shigeo ^b   Satoh, Hidetoshi ^c   Hareyama, Masato ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c SAPPORO CITY GENERAL HOSPITAL   (Japan)

^d HOKKAIDO CANCER CENTER   (Japan)

Author keywords

In field control; Mature T NK cell lymphoma; Non Hodgkin's lymphoma; Radiation dose response; WHO classification

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; PLATINUM DERIVATIVE; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL MATURATION; CELL TYPE; DISEASE CLASSIFICATION; DISEASE CONTROL; DOSE RESPONSE; FEMALE; HISTOPATHOLOGY; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; T CELL LYMPHOMA; TIME SERIES ANALYSIS; WORLD HEALTH ORGANIZATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 33745007365     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.03.014     Document Type: Article

References (18)

1. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The non-hodgkin's lymphoma classification project. Blood 89 (1997) 3909-3918
2. Melnyk A., Rodriguez A., Pugh W.C., et al. Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma. Blood 89 (1997) 4514-4520
3. Cheng A.L., Chen Y.C., Wang C.H., et al. Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades-should peripheral T-cell lymphoma be considered separately?. J Clin Oncol 7 (1989) 725-731
4. Sakata K., Hareyama M., Ohuchi A., et al. Treatment of lethal midline granuloma type nasal T-cell lymphoma. Acta Oncol 36 (1997) 307-311
5. Gisselbrecht C., Gaulard P., Lepage E., et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Blood 92 (1998) 76-82
6. Chen H.H., Fong L., Su I.J., et al. Experience of radiotherapy in lethal midline granuloma with special emphasis on centrofacial T-cell lymphoma: a retrospective analysis covering a 34-year period. Radiother Oncol 38 (1996) 1-6
7. Tsutsui K., Shibamoto Y., Yamabe H., et al. A radiotherapeutic experience for localized extranodal non-Hodgkin's lymphoma: prognostic factors and re-evaluation of treatment modality. Radiother Oncol 21 (1991) 83-90
8. Weidmann E., Boehrer S., Chow K.U., et al. Treatment of aggressive, or progressing indolent peripheral T- and NK-cell neoplasias by combination of fludarabine, cyclophosphamide and doxorubicine. Onkologie 24 (2001) 162-164
9. Harris N.L., Jaffe E.S., Stein H., et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84 (1994) 1361-1392
10. Harris N.L., Jaffe E.S., Diebold J., et al. World health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting-airlie house, Virginia, November 1997. J Clin Oncol 17 (1999) 3835-3849
11. Koom W.S., Chung E.J., Yang W.I., et al. Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpoints. Int J Radiat Oncol Biol Phys 59 (2004) 1127-1137
12. Ferreri A.J., Reni M., and Villa E. Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials. Ann Oncol 11 (2000) 927-937
13. Pellatt J., Sweetenham J., Pickering R.M., et al. A single-centre study of treatment outcomes and survival in 120 patients with peripheral T-cell non-Hodgkin's lymphoma. Ann Hematol 81 (2002) 267-272
14. Sakata K., Satoh M., Someya M., et al. Analysis of local control in patients with non-Hodgkin's lymphoma according to the WHO classification. Strahlenther Onkol 181 (2005) 385-391
15. Yamaguchi M., Kita K., Miwa H., et al. Frequent expression of p-glycoprotein/MDR1 by nasal T-cell lymphoma cells. Cancer 76 (1995) 2351-2356
16. Kim G.E., Lee S.W., Chang S.K., et al. Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck. Radiother Oncol 61 (2001) 261-269
17. Horning S.J., Glick J.H., Kim K., et al. Final report of E1484: CHOP vs. CHOP+Radiotherapy (RT) for limited stage diffuse aggressive lymphoma. Proceedings of ASH 98 (2001) 724a
18. Miller T.P., Dahlberg S., Cassady J.R., et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med 339 (1998) 21-26